Page last updated: 2024-12-06

monoethylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Monoethylcholine (MEC) is a quaternary ammonium compound that serves as a precursor to acetylcholine (ACh), a neurotransmitter essential for various physiological processes. MEC is synthesized through the methylation of choline, catalyzed by the enzyme choline O-methyltransferase (COMT). It is a potent inhibitor of acetylcholinesterase (AChE), the enzyme responsible for degrading ACh in the synaptic cleft, thereby prolonging the action of ACh. MEC has been shown to enhance cognitive function and memory in animal models, suggesting potential therapeutic applications for Alzheimer's disease and other neurodegenerative disorders. Its ability to cross the blood-brain barrier makes it a promising candidate for drug development. However, MEC is also associated with certain adverse effects, such as increased heart rate and muscle weakness. Extensive research is underway to understand its full pharmacological profile and optimize its therapeutic potential.'

monoethylcholine: competitively inhibits transport of choline; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25781
CHEMBL ID105536
SCHEMBL ID1598462
MeSH IDM0083330

Synonyms (15)

Synonym
ethyl-(2-hydroxy-ethyl)-dimethyl-ammonium
bdbm50147116
monoethylcholine
CHEMBL105536 ,
ethyl-(2-hydroxyethyl)-dimethylazanium
ethanaminium, n-ethyl-2-hydroxy-n,n-dimethyl-
13205-69-1
unii-6j5qmu852f
6j5qmu852f ,
ethylcholine
dimethylethylcholine
n,n,n-dimethylmonoethylaminoethanol
SCHEMBL1598462
DTXSID00157326
Q27264989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID52133Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (22.22%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]